HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis

Nickoloff, 1999, Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161, Arch Dermatol, 135, 546, 10.1001/archderm.135.5.546

Leigh, 1995, Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro, Br J Dermatol, 133, 501, 10.1111/j.1365-2133.1995.tb02696.x

Baker, 2001, Skin T cell proliferative response to M protein and other cell wall and membrane proteins of group A streptococci in chronic plaque psoriasis, Clin Exp Immunol, 124, 516, 10.1046/j.1365-2249.2001.01563.x

Fierlbeck, 1990, Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations, Arch Dermatol, 126, 351, 10.1001/archderm.126.3.351

Sigmundsdottir, 1997, Circulating T cells of patients with active psoriasis respond to streptococcal M-peptides sharing sequences with human epidermal keratins, Scand J Immunol, 45, 688, 10.1046/j.1365-3083.1997.d01-438.x

Gudmundsdottir, 1999, Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis?, Clin Exp Immunol, 117, 580, 10.1046/j.1365-2249.1999.01013.x

Sambrook, 1989

Kuwana, 1998, Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody, J Clin Invest, 102, 1393, 10.1172/JCI4238

Wrone-Smith, 1996, Dermal injection of immunocytes induces psoriasis, J Clin Invest, 98, 1878, 10.1172/JCI118989

Ho, 2004, The use of cyclosporin in psoriasis: a clinical review, Br J Dermatol, 150, 1, 10.1111/j.0366-077X.2004.05950.x

Skov, 2003, HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris, Arch Dermatol, 139, 1433, 10.1001/archderm.139.11.1433

Gottlieb, 1995, Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggest a primary immune, but not keratinocyte pathogenic basis, Nat Med, 1, 442, 10.1038/nm0595-442

Gudjonsson, 2004, Immunopathogenic mechanisms in psoriasis, Clin Exp Immunol, 135, 1, 10.1111/j.1365-2249.2004.02310.x

Baker, 1993, Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions, Br J Dermatol, 128, 493, 10.1111/j.1365-2133.1993.tb00224.x

Fierlbeck, 1990, Psoriasis induced at the injection site of recombinant interferon gamma, Arch Dermatol, 126, 351, 10.1001/archderm.1990.01670270083013

Uyemura, 1993, The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response, J Invest Dermatol, 101, 701, 10.1111/1523-1747.ep12371679

Flohr, 1992, Interferon-γ regulates expression of a novel keratin class I gene, Eur J Immunol, 22, 975, 10.1002/eji.1830220415

Hammer, 1993, Promiscuous and allele-specific anchors in HLA-DR-binding peptides, Cell, 74, 197, 10.1016/0092-8674(93)90306-B

Singh, 2001, ProPred: prediction of HLA-DR binding sites, Bioinformatics, 17, 1236, 10.1093/bioinformatics/17.12.1236

Green, 2003, Activation-induced cell death in T cells, Immunol Rev, 193, 70, 10.1034/j.1600-065X.2003.00051.x

Wesselborg, 1993, Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells, J Immunol, 150, 4338, 10.4049/jimmunol.150.10.4338